Speech-Language Pathologists in Lowell, MA Accepting Medicare

69 Speech-Language Pathologists found. Showing 61 - 69

Rebecca Myhill, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1230 Bridge St, Lowell, MA 01850 Phone: 978-955-5955

Danielle Culcasi Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 557 Varnum Ave, Lowell, MA 01854 Phone: 978-454-5444

Catherine Ann Geary, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 295 Varnum Ave, Lowell, MA 01854 Phone: 978-937-6403    Fax: 978-788-7955

Kristin Laura Jauch Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Princeton Blvd, Lowell, MA 01851 Phone: 978-454-8086

Emily Ann Tyler, M.S. SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Princeton Blvd, Lowell, MA 01851 Phone: 978-454-8086

Nancy Clancy, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: South Bay Community Services, 142 Warren St, Lowell, MA 01852 Phone: 978-452-1739

Nina Remy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 126 Phoenix Ave, Lowell, MA 01852 Phone: 978-453-8331

Janice Lau, MA, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 126 Phoenix Ave, Building #2, Lowell, MA 01852 Phone: 978-453-8331

Urvi Solanki Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 841 Merrimack St, Lowell, MA 01854 Phone: 908-442-9213

News Archive

Researchers reveal totally new biological mechanism that underlies cancer

In a landmark study, researchers from the Broad Institute and Massachusetts General Hospital reveal a completely new biological mechanism that underlies cancer. By studying brain tumors that carry mutations in the isocitrate dehydrogenase (IDH) genes, the team uncovered some unusual changes in the instructions for how the genome folds up on itself.

Study: Use of hand disinfection, aseptic techniques during risk-prone invasive procedures is very low

An observational study by Sahlgrenska Academy researchers at a large Swedish hospital found 2,393 opportunities for hand disinfection and/or aseptic techniques. Doctors and nurses missed 90% of the opportunities.

Idenix Pharmaceuticals prices underwritten offering of common stock at $4.35 per share

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the pricing of an underwritten offering of 6,460,672 shares of its common stock at a price of $4.35 per share. After the underwriting discount and estimated offering expenses payable by the company, the company expects to receive net proceeds of approximately $26.2 million. All of the shares are being sold by Idenix.

Exposure to Dioxin linked to increased heart problems

Dioxins, environmental pollutants resulting from the production and combustion of chlorinated compounds, have been linked to an increase in ischemic heart disease (IHD) and cardiovascular disease (CVD) mortality rates, as reported in a review article in the November 2008 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).

Read more Medical News

› Verified 2 days ago

• 1
• 2
• 3
• 4(current)